Mounjaro vs Ozempic 2026 — The Complete Comparison

The short answer: Mounjaro wins on weight loss, Ozempic wins on established data

Mounjaro (tirzepatide) produces approximately 20–22% body weight loss in clinical trials. Ozempic (semaglutide) produces approximately 12–15%. The difference is real and clinically significant — but Ozempic has more years of post-market safety data. For patients whose primary goal is maximum weight loss, Mounjaro has the stronger evidence. For patients who want the most established track record, Ozempic has been used by more people for longer.

FactorOzempic (semaglutide)Mounjaro (tirzepatide)
Active ingredientSemaglutideTirzepatide
MechanismGLP-1 receptor agonistDual GLP-1 + GIP receptor agonist
Primary approvalType 2 diabetesType 2 diabetes
Weight loss approvalWegovy (2.4mg version)Zepbound (weight loss version)
Average weight loss~12–15% body weight~20–22% body weight
Patients losing 20%+~32%~57%
Nausea rates~44%Slightly lower for some patients
Brand-name cost~$960/mo (Ozempic)~$1,050/mo (Mounjaro)
Compounded costFrom ~$99/moFrom ~$149/mo
Years of market dataMore establishedGrowing rapidly
Cardiovascular dataSELECT trial — strongEvidence growing

Why Mounjaro produces more weight loss

Mounjaro activates both GLP-1 and GIP receptors. Ozempic activates only GLP-1. GIP is a gut hormone involved in fat metabolism and insulin signaling through pathways that don't overlap with GLP-1. Activating both pathways simultaneously produces additive — possibly synergistic — effects on appetite suppression and fat metabolism that semaglutide's single mechanism can't match.

Who should choose Ozempic/semaglutide

Who should choose Mounjaro/tirzepatide

Access both semaglutide and tirzepatide

DirectMeds offers both compounded semaglutide and tirzepatide — your physician determines which is right for you. From ~$99/month.

Check eligibility at DirectMeds →
Is Mounjaro stronger than Ozempic?
Yes, in terms of weight loss outcomes. Mounjaro (tirzepatide) produces an average of 20–22% body weight loss versus 12–15% for Ozempic (semaglutide). This difference is driven by tirzepatide's dual GLP-1/GIP mechanism versus semaglutide's single GLP-1 mechanism. "Stronger" doesn't necessarily mean better for every patient — factors like side effect tolerance, cost, and specific health conditions should inform the choice.
Can I switch from Ozempic to Mounjaro?
Yes — switching from semaglutide to tirzepatide is a common and clinically supported approach, particularly for patients who plateau on semaglutide or want stronger results. Your provider will guide the transition, which typically involves starting tirzepatide at a low dose and titrating. There's usually a brief adjustment period when switching between GLP-1 medications.
Does Mounjaro cause more side effects than Ozempic?
The side effect profiles are similar — both primarily cause GI side effects (nausea, diarrhea, vomiting, constipation). Some studies suggest tirzepatide may cause slightly less nausea than semaglutide but slightly more diarrhea. For most patients the experience is comparable. Side effect management strategies (dietary changes, slower titration, nighttime injection) are the same for both medications.
Is compounded Mounjaro the same as brand-name?
Compounded tirzepatide uses the same active molecule as Mounjaro and Zepbound. The clinical mechanism, expected outcomes, and side effect profile are identical at equivalent doses because the drug is the same molecule. The difference is manufacturing source, regulatory pathway, and cost — compounded tirzepatide costs ~$149/month versus ~$1,050/month for brand-name Mounjaro.